Ke Dan, Zhang Zhen, Liu Jieting, Chen Peijian, Li Jialing, Sun Xinhai, Chu Yanhui, Li Luxin
College of Life Sciences, Mudanjiang Medical University, Mudanjiang, China.
Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Mudanjiang Medical University, Mudanjiang, China.
Front Cardiovasc Med. 2023 Mar 10;10:1135723. doi: 10.3389/fcvm.2023.1135723. eCollection 2023.
Diabetes is a common chronic metabolic disease, and its incidence continues to increase year after year. Diabetic patients mainly die from various complications, with the most common being diabetic cardiomyopathy. However, the detection rate of diabetic cardiomyopathy is low in clinical practice, and targeted treatment is lacking. Recently, a large number of studies have confirmed that myocardial cell death in diabetic cardiomyopathy involves pyroptosis, apoptosis, necrosis, ferroptosis, necroptosis, cuproptosis, cellular burial, and other processes. Most importantly, numerous animal studies have shown that the onset and progression of diabetic cardiomyopathy can be mitigated by inhibiting these regulatory cell death processes, such as by utilizing inhibitors, chelators, or genetic manipulation. Therefore, we review the role of ferroptosis, necroptosis, and cuproptosis, three novel forms of cell death in diabetic cardiomyopathy, searching for possible targets, and analyzing the corresponding therapeutic approaches to these targets.
糖尿病是一种常见的慢性代谢性疾病,其发病率逐年持续上升。糖尿病患者主要死于各种并发症,其中最常见的是糖尿病心肌病。然而,在临床实践中,糖尿病心肌病的检出率较低,且缺乏针对性治疗。最近,大量研究证实,糖尿病心肌病中的心肌细胞死亡涉及细胞焦亡、凋亡、坏死、铁死亡、坏死性凋亡、铜死亡、细胞自噬等过程。最重要的是,大量动物研究表明,通过抑制这些调节性细胞死亡过程,如使用抑制剂、螯合剂或基因操作,可以减轻糖尿病心肌病的发生和发展。因此,我们综述了铁死亡、坏死性凋亡和铜死亡这三种新型细胞死亡形式在糖尿病心肌病中的作用,寻找可能的靶点,并分析针对这些靶点的相应治疗方法。